Form 4: Avanos Medical Interim CEO Michael Greiner Reports Share Disposals to Cover Tax Obligations
SEC Form 4 Filing
Michael Greiner, Interim CEO of Avanos Medical, reports disposing of shares to cover tax obligations related to vesting restricted share units.
Summary
- On March 6, 2025, Michael Greiner, Interim CEO of Avanos Medical, disposed of shares to cover tax withholding obligations.
- 5,112 shares were surrendered at a price of $15.3 to cover taxes on vesting of 11,424 time-based restricted share units (TRSUs) awarded on March 6, 2023, which vested on March 6, 2025.
- An additional 8,485 shares were surrendered at a price of $15.3 to cover taxes on vesting of 18,965 time-based restricted share units (TRSUs) awarded on March 6, 2024, which vested on March 6, 2025.
- Following these transactions, Greiner beneficially owns 189,948 shares of Avanos Medical.
- The transactions were reported on Form 4, filed with the SEC on March 10, 2025.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, as it simply reports required information.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the Interim CEO's transactions related to vested stock awards.
Stakeholder Impact
- The share disposals are unlikely to have a significant impact on shareholders, as they are related to tax obligations and represent a small percentage of the total outstanding shares.
Key Dates
| Date | Description |
|---|---|
| 03/06/2023 | Date of award of 11,424 time-based restricted share units (TRSUs) which vested on March 6, 2025. |
| 03/06/2024 | Date of award of 18,965 time-based restricted share units (TRSUs) which vested on March 6, 2025. |
| 03/06/2025 | Date of share disposals to cover tax withholding obligations upon vesting of TRSUs. |
| 03/10/2025 | Date of Form 4 filing with the SEC. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.